• WKN: A0LR93
  • ISIN: DE000A0LR936
  • Land: Deutschland

Nachricht vom 27.04.2021 | 20:26

STEICO SE: Sales soar in first quarter. EBIT more than doubles.

DGAP-News: STEICO SE / Key word(s): Annual Report/Quarterly / Interim Statement
27.04.2021 / 20:26
The issuer is solely responsible for the content of this announcement.

STEICO SE: Sales soar in first quarter. EBIT more than doubles.

* Preliminary figures confirmed by final financial statements 2020

* The board of administration proposes a dividend of 0.30 Euro per share for the financial year 2020

Feldkirchen near Munich, 27 April 2021 - Today the STEICO group (ISIN DE000A0LR936) released its annual report for the financial year 2020 and its interim report for the first quarter 2021.

Business Development 2020

KPI 2020 2019
Revenue 308.8 €m 281.0 €m
Total operating revenue (TOR) 306.9 €m 287.8 €m
EBITDA 57.0 €m 56.7 €m
EBITDA-Margin in % TOR 18.6 % 19.7 %
EBIT 33.6 €m 32.5 €m
EBIT-Margin in % TOR 10.9 % 11.3 %
Consolidated net income 23.0 €m 22.8 Mio €m
Earnings per share 1.63 € 1.62 €
Equity ratio in %
(as of 31.12.)

53.0 %

53.7 %

The first half of 2020 was dominated by the COVID-19 pandemic and the associated restrictions. The second half of the year, on the other hand, was characterized by a dynamic increase in demand, especially for wood-fibre insulation materials.

The German core market recorded continuous growth throughout the year. Most other markets, including the second-largest market France, recorded significant catch-up effects in the second half of the year and closed the year as a whole with higher revenues.

In total, we recorded revenue growth of 9.9% to € 308.8 million. Earnings also increased slightly despite the demanding challenges posed by the pandemic. EBITDA totalled € 57.0 million, up 0.5% year on year. EBIT was up 3.4% year-on-year at € 33.6 million. At € 23.0 million, net income lifted by 0.8% compared to the previous year.

Earnings per share amounted to 1.63 € (previous year: 1.62 €).


Sales soar in first quarter. EBIT more than doubles.

Building and insulating with wood is more attractive than ever. As a result, the dynamic increase in demand continued in the first quarter of 2021. The STEICO Group recorded a 21.8% surge in sales to €90.6 million, with a simultaneous disproportionately high increase in earnings. EBIT rose by 128.9% to € 13.8 million, while net income for the period, at € 8.7 million, was 141.9% higher than in the same quarter of the previous year. STEICO thus recorded by far the most successful first quarter in the company's history.

In order to continue to meet the increasing demand, STEICO is currently pursuing the largest investment program in the company's history. With a focus on wood fiber insulating materials, capacities are not only being expanded at the existing locations. In Gromadka, Poland, STEICO is also investing in the construction of a completely new insulation materials plant.

KPI Q1 2021 Q1 2020
Revenue 90.6 €m 74.4 €m
Total operating revenue (TOR) 88.3 €m 72.5 €m
EBITDA 19.0 €m 12.1 €m
EBITDA-Margin in % TOR 21.5 % 16.7 %
EBIT 13.8 €m 6.0 €m
EBIT-Margin in % TOR 15.6 % 8.3 %
Profit of the period 8.7 €m 3.6 €m

Dividend proposal

Based on the positive business development the board of administration proposes to annual general meeting to appropriate the net retained profits in 2020 to pay a dividend of 0.30 € per share (dividend 2019: 0.25 € per share). The volume of the dividend distribution would amount to 4,225,039.50 € in total.


Management remains very optimistic about the full year 2021 and believes the Group is excellently positioned to continue its growth. As a result of the excellent start to the year, expectations for the year as a whole are being adjusted upwards. Unless there are additional negative effects from developments in the pandemic, the Board of Directors believes that in 2021 revenues will lift by more than 15% with an EBIT ratio of between 13.0% and 15.0% (in terms of total operating revenue).

The complete financial reports can be downloaded at

Company Profile
STEICO develops, produces and markets ecological construction products made of renewable raw materials. STEICO is the European market leader in the wood-fibre insulation materials segment.

STEICO is positioned as a system provider for ecological residential construction and is the only manufacturer in the industry to offer an integrated wooden construction system in which insulation material and construction components supplement each other. These include flexible and stable wood fiber insulation panels, composite thermal insulation systems, insulation panels
with a reinforcing effect, as well as cavity wall insulation made of wood fibers and cellulose. The construction elements comprise I-joists and Laminated Veneer Lumber (LVL). In addition, the STEICO group also produces fiberboard and operates in the wood trade.

The Munich-based company's products are used in new construction and when renovating roofs, walls, ceilings, floors and facades. STEICO's products allow the construction of future-proof, healthy buildings with a particularly high quality of living and a healthy atmosphere. STEICO's products offer reliable protection against cold, heat and also noise, and they permanently improve the building's energy efficiency

Andreas Schulze
Otto-Lilienthal-Ring 30
85622 Feldkirchen
Fon: +49-(0)89-99 15 51-548
Fax: +49-(0)89-99 15 51-704

27.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie


Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021